TRex Bio
Jose Valle has worked in the biotechnology and pharmaceutical industries since 2008. Jose began their career at Multispan, Inc. as a Research Associate I, where they conducted various bioassays and established mammalian cell lines that stably expressed recombinant proteins. In 2011, they joined Bristol-Myers Squibb as a Research Associate IV, where they managed numerous murine tumor studies and conducted ex-vivo immunophenotyping of lymphocytes in tumor micro-environment by multi-color flow cytometry. Most recently, they have been a Senior Scientist at TRexBio, where they have developed and optimized various assays in a proprietary screening platform to identify and validate novel Treg targets that modulate the immune response in autoimmune, inflammatory and fibrotic diseases as well as cancer. Jose has also presented findings from screening and validation efforts in various forums to internal leadership and collaboration partners.
Jose Valle graduated from the Massachusetts Institute of Technology in 2007 with a Bachelor of Science (BS) in Biology, General.
TRex Bio
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.